Neostigmine- and edrophonium-induced reversal of moderate or profound mivacurium block;Neostigmin und Edrophonium. Antagonisierung einer tiefen und oberflachlichen Mivacuriumblockade

Anaesthesist

Volumn 46, Issue 2, 1997, Pages 96-100

  Bartunek, A ^a   Gilly, H ^a,b   Huemer, G ^a   Yildiz, S ^a   Schramm, W ^a   Lackner, F X ^a   Foldes, F F ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

edrophonium; mivacurium; neostigmine

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; EDROPHONIUM; FENTANYL; MIVACURIUM; NEOSTIGMINE; NITROUS OXIDE; THIOPENTAL;

ADULT; AGED; ANESTHETIC RECOVERY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEUROMUSCULAR BLOCKING;

ADOLESCENT; ADULT; AGED; ANESTHESIA, GENERAL; CHOLINESTERASE INHIBITORS; EDROPHONIUM; ELECTRIC STIMULATION; FEMALE; HUMANS; ISOQUINOLINES; MALE; MIDDLE AGED; NEOSTIGMINE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RESUSCITATION;

EID: 0030994651     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050377     Document Type: Article

References (24)

1. Abdulatif M (1995) Recovery characteristics after early administration of anticholinesterases during intense mivacurium-induced neuromuscular block. Br J Anaesth 74:20-25
2. Abdulatif M, Al-Ghamdi A, Al-Sanabary M, Abdel-Gaffar ME (1996) Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children. Br J Anaesth 76:239-244
3. Baurain MJ, Dernovoi BS, d'Hollander AA, Hennart DA (1994) Comparison of neostigmine-induced recovery with spontaneous recovery from mivacurium induced neuromuscular block. Br J Anaesth 73:791-794
4. Beemer GH, Bjorksten AR, Dawson PJ, Dawson RJ, Heenan PJ, Robertson BA (1991) Determinants of the reversal time of competitive neuromuscular block by anticholinesterases. Br J Anaesth 66:469-475
5. Bevan DR, Donati F, Kopman AF (1992) Reversal of neuromuscular blockade. Anesthesiology 77:785-804
6. Caldwell JE, Robertson EN, Baird WLM (1986) Antagonism of profound neuromuscular blockade induced by vecuronium or atracurium. Br J Anaesth 58:1285-1289
7. Connolly FM, Mirakhur RK, Loan PB, McCoy EP, Symington M, Kumar N (1995) Antagonism of mivacurium block with edrophonium from various degrees of spontaneous recovery. Br J Anaesth 74:229-230
8. Cook DR, Chakravorti S, Brandom BW, Stiller RL (1992) Effects of neostigmine, edrophonium and succinylcholine on the in vitro metabolism of mivacurium: Clinical correlates. Anesthesiology 77:A948
9. Cook DR, Stiller RL, Weakly JN, Chakravorti S, Brandom BW, Welch RM (1989) In vitro metabolism of mivacurium chloride (BW B1090 U) and succinylcholine. Anesth Analg 68:452-459
10. Cronelly R, Morris RB, Miller RD (1982) Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia. Anesthesiology 57:262-266
11. Devcic A, Munshi CA, Gandhi SK, Kampine JP (1995) Antagonism of mivacurium neuromuscular block: Neostigmine versus edrophonium. Anesth Analg 81:1005-1009
12. Donati F, Smith CE, Bevan DR (1989) Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade. Anesth Analg 68:13-19
13. Foldes FF (1978) Enzymes of acetylcholine metabolism. In: Foldes FF (ed) Enzymes in anesthesiology. Springer, New York, pp 91-147
14. Foldes FF, Nagashima H, Nguyen HD, Schiller WS, Mason MM, Ohta Y (1991) The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. Anesthesiology 75:191-196
15. Hart PS, Wright PMC, Brown R, Lau M., Sharma ML, Miller RD, Gruenke L, Fisher DM (1995) Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis. Anesthesiology 82:912-918
16. Hauner H (1995) Dysfunktionen des Energie-stoffwechsels. In: Biesalski HK, Fürst P, Kasper H, Kluthe R, Pölert W, Puchstein C, Stählin HB (Hrsg) Ernährungsmedizin.Thieme, Stuttgart New York, S 187-212
17. Kopman AF (1986) Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions. Anesthesiology 65:572-578
18. Kopman AF (1993) The pharmacokinetics of anticholinesterases. Anaesthetic Pharmacol Rev 1:88-92
19. Kopman AF, Mallhi MU, Justo MD, Rodricks P, Neuman GG (1994) Antagonism of mivacurium-induced neuromuscular blockade in humans. Anesthesiology 81:1394-1400
20. 2O-enflurane-alfentanil anaesthesia. Can J Anaesth 42:879-883
21. Miller DR, Bryson G, Martineau RJ, Kitts JB, Curran M, Bragg P, Watson JB, Hull K, Lindsay P (1995) Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium. Can J Anaesth 42:996-1002
22. Mirakhur RK (1986) Edrophonium and plasma cholinesterase activity. Can Anaesth Soc J 33:588-590
23. Naguib M, Abdulatif M, Al-Ghamdi A, Hamo I, Nouheid R (1993) Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block. Br J Anaesth 71:709-714
24. Savarese JJ, Ali HH, Basta SJ, Embree PB, Scott RPF, Sunder N, Weakly JN, Wastila WB, El Sayad HA (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090 U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 68:723-732